Repligen beats top-line and bottom-line estimates; updates FY25 outlook

* Repligen press release [https://seekingalpha.com/pr/20281673-repligen-reports-third-quarter-2025-financial-results-and-updates-full-year-2025-financial] (NASDAQ:RGEN [https://seekingalpha.com/symbol/RGEN]): Q3 Non-GAAP EPS of $0.46 beats by $0.04.
* Revenue of $188.81M (+21.9% Y/Y) beats by $7.09M, _and 18% organic with double-digit reported growth across all franchises._
* There was no COVID-related revenue in either reporting period.
* _Orders increased sequentially and greater than 20% year-over-year._
* _Increasing revenue guidance to a range of $729 to $737 million, which represents 14% -15.5% year-over-year non-COVID organic growth._
*
Cash and cash equivalents at September 30, 2025, were $749 million, compared to $757 million at December 31, 2024.

FINANCIAL GUIDANCE FOR FULL YEAR 2025

_ALL ADJUSTED FIGURES ARE NON-GAAP_

Our financial guidance for the full year 2025 is based on expectations for our existing business. Our GAAP and Adjusted (non-GAAP) guidance excludes the impact of any potential or pending business acquisitions in 2025, and future fluctuations in foreign currency exchange rates.

CURRENT GUIDANCE

(at October 28, 2025)

FY 2025

GAAP

Adjusted (non-GAAP)

Total Reported Revenue

$729M - $737M
(PRIOR $715M - $735M) VS. $727.50M CONSENSUS
$729M - $737M

Reported Growth

15% - 16%

15% - 16%

Organic Growth

-

12% - 13.5%

Organic, Non-COVID Growth

-

14% - 15.5%

Non-COVID Growth

-

17% - 18%

Gross Margin

51.5% - 52.5%

52% - 53%

Income from Operations

$50M - $52M

$98M - $100M

Operating Margin

~7%

~13.5%

Other Income (Expense)

~$7.5M

~$21M

Adjusted EBITDA Margin

-

~19%

Tax Rate on Pre-Tax Income

17% - 18%

21% - 22%

Net Income

$46.5M - $48M

$93.5M - $95M

Earnings Per Share - Diluted

$0.82 - $0.85

$1.65 - $1.68 (PRIOR $1.65 - $1.72) VS. $1.69 CONSENSUS

Click to enlarge

MORE ON REPLIGEN

* Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2025 Transcript [https://seekingalpha.com/article/4825806-repligen-corporation-rgen-presents-at-bank-of-america-global-healthcare-conference-2025]
* Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2025 - Slideshow [https://seekingalpha.com/article/4825789-repligen-corporation-rgen-presents-at-bank-of-america-global-healthcare-conference-2025]
* Repligen Corporation (RGEN) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript [https://seekingalpha.com/article/4819458-repligen-corporation-rgen-presents-at-wells-fargo-20th-annual-healthcare-conference-2025]
* Repligen Q3 2025 Earnings Preview [https://seekingalpha.com/news/4508806-repligen-q3-2025-earnings-preview]
* Repligen higher as HSBC initiates at Buy on growth prospects [https://seekingalpha.com/news/4500732-repligen-higher-hsbc-initiates-buy]